-
5HTP Regulation Of Asthma In Children
NCT04160910 ·
Phase: Phase 2 ·
Ages: 8 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
NCT07532265 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 14 locations
-
A Clinical Trial of Soluble Fiber for Asthma
NCT06372249 ·
Phase: Phase 2 ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
NCT07677059 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
NCT07525375 ·
Phase: Phase 2 ·
Ages: 4 Years to 11 Years ·
Sex: All (male and female) · 43 locations
-
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 12 locations
-
A Study of CM310 in Subjects With Moderate to Severe Asthma
NCT05761028 ·
Phase: Phase 2, Phase 3 ·
Ages: 12 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
NCT07323654 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 71 locations
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 121 locations
-
A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
NCT06441812 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581 ·
Phase: Phase 2 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female) · 132 locations
-
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
NCT03762395 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms
NCT05028153 ·
Phase: Phase 2 ·
Ages: 12 Months to 71 Months ·
Sex: All (male and female) · 1 location
-
Azithromycin for Critical Asthma - Pediatrics
NCT06223828 ·
Phase: Phase 2, Phase 3 ·
Ages: 3 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
NCT06932263 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 221 locations
-
Dose-Ranging Study of LQ036 Single-Domain Antibody Nebulization Solution in Poorly Controlled Asthma
NCT07589439 ·
Phase: Phase 2 ·
Ages: 12 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
NCT07301255 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 18 locations
-
Efficacy of L-menthol on Breathlessness in Asthma
NCT07500974 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough
NCT05110144 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
NCT07342803 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Escitalopram in Asthma Patients With Frequent Exacerbation
NCT06216535 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
NCT05008965 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 13 locations
-
High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children
NCT05043116 ·
Phase: Phase 2 ·
Ages: 12 Months to 71 Months ·
Sex: All (male and female) · 1 location
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
NCT06273072 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Omalizumab Before Onset of Exacerbations
NCT05332067 ·
Phase: Phase 2 ·
Ages: 6 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Pediatric Asthma Trial of Corticosteroid Heterogeneity (PATCH): Trial of Dexamethasone Versus Methylprednisolone for Pediatric Critical Asthma
NCT07455396 ·
Phase: Phase 2 ·
Ages: 3 Years to 17 Years ·
Sex: All (male and female) · 1 location
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
NCT05222529 ·
Phase: Phase 2 ·
Ages: 6 Years to 11 Years ·
Sex: All (male and female) · 23 locations
-
Phase II Trial of RC1416 Injection in Asthma
NCT07403487 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 44 locations
-
Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge
NCT07059767 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 2 locations
-
RIG 101 Trial in Healthy Adults and Adults With Asthma
NCT07488897 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 2 locations
-
Rademikibart IV for Acute Asthma and COPD Exacerbation
NCT07705737 ·
Phase: Phase 2 ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female) · 4 locations
-
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
NCT02947945 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
NCT07326995 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
NCT06960382 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
NCT05667701 ·
Phase: Phase 2 ·
Ages: 2 Months to 12 Months ·
Sex: All (male and female) · 2 locations
-
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
NCT07011524 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
NCT07241546 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 5 locations
-
Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma
NCT07245368 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 8 locations
-
Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06775340 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
NCT07324707 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
NCT05259904 ·
Phase: Phase 2 ·
Ages: 18 Years to 70 Years ·
Sex: All (male and female) · 1 location
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
NCT03885245 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
NCT07301736 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 167 locations
-
VENTURI (VENTilation Using Respiratory Imaging)
NCT07282886 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Viral Mucosal Reprogramming
NCT05331170 ·
Phase: Phase 2 ·
Ages: 18 Years to 60 Years ·
Sex: All (male and female) · 1 location
-
Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease
NCT02740868 ·
Phase: Phase 2 ·
Ages: 8 Years and older ·
Sex: All (male and female) · 1 location